Auburn's wellness culture drives strong interest in GLP-1 treatments. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate program for Auburn residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, with the provider evaluation, the medication, ongoing care, and home delivery to Auburn included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Auburn is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Auburn, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Wegovy® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2021 for Chronic weight management. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Auburn residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Suburban life around Auburn comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Semaglutide therapy addresses biology involved in weight regulation by reducing hunger signals, so Auburn area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month, delivered to your door. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.